Hwail Pharmaceutical Co.Ltd
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.
Hwail Pharmaceutical Co.Ltd (061250) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.033x
Based on the latest financial reports, Hwail Pharmaceutical Co.Ltd (061250) has a cash flow conversion efficiency ratio of 0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.82 Billion) by net assets (₩207.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hwail Pharmaceutical Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Hwail Pharmaceutical Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hwail Pharmaceutical Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hwail Pharmaceutical Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Link Prop Investment AB
ST:LINKAB
|
0.102x |
|
DOD Biotech Public Company Limited
BK:DOD
|
0.016x |
|
China Yurun Food Group Limited
F:C7Y
|
0.016x |
|
Tribeca Resources Corporation
PINK:TRRCF
|
-0.054x |
|
KRISHIVAL
NSE:KRISHIVAL
|
N/A |
|
Rcm Beteiligungs AG
F:RCMN
|
N/A |
|
Intikeramik Alamasri Industri
JK:IKAI
|
0.041x |
|
San Lorenzo Gold Corp
PINK:SNLGF
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Hwail Pharmaceutical Co.Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Hwail Pharmaceutical Co.Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩203.42 Billion | ₩11.63 Billion | 0.057x | +42.04% |
| 2023-12-31 | ₩174.45 Billion | ₩7.02 Billion | 0.040x | +3126.94% |
| 2022-12-31 | ₩175.57 Billion | ₩-233.56 Million | -0.001x | -101.20% |
| 2021-12-31 | ₩181.66 Billion | ₩20.09 Billion | 0.111x | +8700.50% |
| 2020-12-31 | ₩156.86 Billion | ₩-201.69 Million | -0.001x | -104.16% |
| 2019-12-31 | ₩119.43 Billion | ₩3.69 Billion | 0.031x | -56.33% |
| 2018-12-31 | ₩101.25 Billion | ₩7.17 Billion | 0.071x | -16.62% |
| 2017-12-31 | ₩98.18 Billion | ₩8.34 Billion | 0.085x | -11.50% |
| 2016-12-31 | ₩99.86 Billion | ₩9.58 Billion | 0.096x | +237.50% |
| 2015-12-31 | ₩98.94 Billion | ₩-6.90 Billion | -0.070x | -123.28% |
| 2014-12-31 | ₩89.07 Billion | ₩-2.78 Billion | -0.031x | -138.69% |
| 2013-12-31 | ₩86.31 Billion | ₩6.97 Billion | 0.081x | +561.06% |
| 2012-12-31 | ₩82.22 Billion | ₩1.00 Billion | 0.012x | -89.19% |
| 2011-12-31 | ₩69.49 Billion | ₩7.86 Billion | 0.113x | -- |